Ossianix Announces Publication of Positive Preclinical Data on Neutralizing SARS-CoV-2 Infection with a Panel of Single Domain Shark VNAR Antibodies

Ossianix Announces Publication of Positive Preclinical Data on Neutralizing SARS-CoV-2 Infection with a Panel of Single Domain Shark VNAR Antibodies

A highly potent panel of VNARs against the SARS-CoV-2 spike protein has been isolated

Neutralization of SARS-CoV-2 was demonstrated in in vitro infectivity assays

In vitro blocking activities were also found against the N501Y and E484K mutants

See more here

Comments are closed.